Structural racism in precision medicine: leaving no one behind

Lester Darryl Geneviève, Andrea Martani, David Shaw, Bernice Simone Elger, Tenzin Wangmo, Lester Darryl Geneviève, Andrea Martani, David Shaw, Bernice Simone Elger, Tenzin Wangmo

Abstract

Background: Precision medicine (PM) is an emerging approach to individualized care. It aims to help physicians better comprehend and predict the needs of their patients while effectively adopting in a timely manner the most suitable treatment by promoting the sharing of health data and the implementation of learning healthcare systems. Alongside its promises, PM also entails the risk of exacerbating healthcare inequalities, in particular between ethnoracial groups. One often-neglected underlying reason why this might happen is the impact of structural racism on PM initiatives. Raising awareness as to how structural racism can influence PM initiatives is paramount to avoid that PM ends up reproducing the pre-existing health inequalities between different ethnoracial groups and contributing to the loss of trust in healthcare by minority groups.

Main body: We analyse three nodes of a process flow where structural racism can affect PM's implementation. These are: (i) the collection of biased health data during the initial encounter of minority groups with the healthcare system and researchers, (ii) the integration of biased health data for minority groups in PM initiatives and (iii) the influence of structural racism on the deliverables of PM initiatives for minority groups. We underscore that underappreciation of structural racism by stakeholders involved in the PM ecosystem can be at odds with the ambition of ensuring social and racial justice. Potential specific actions related to the analysed nodes are then formulated to help ensure that PM truly adheres to the goal of leaving no one behind, as endorsed by member states of the United Nations for the 2030 Agenda for Sustainable Development.

Conclusion: Structural racism has been entrenched in our societies for centuries and it would be naïve to believe that its impacts will not spill over in the era of PM. PM initiatives need to pay special attention to the discriminatory and harmful impacts that structural racism could have on minority groups involved in their respective projects. It is only by acknowledging and discussing the existence of implicit racial biases and trust issues in healthcare and research domains that proper interventions to remedy them can be implemented.

Keywords: Ethics, research; Healthcare inequalities; Precision Medicine; Racial bias; Racial discrimination; Social justice.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Potential actions to reduce the cascading effects of structural racism on the quality of health data collection, integration and deliverables in precision medicine initiatives

References

    1. PMI Working Group. The Precision Medicine Initiative Cohort Program - Building a Research Foundation for 21st Century Medicine [Internet]. National Institutes of Health; 2015. [cited 2019 November 18]. Available from: .
    1. Collins FS, Varmus H. A new initiative on precision Medicine. N Engl J Med. 2015;372(9):793–795. doi: 10.1056/NEJMp1500523.
    1. Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17:507. doi: 10.1038/nrg.2016.86.
    1. Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. New Biotechnol. 2012;29(6):613–624. doi: 10.1016/j.nbt.2012.03.004.
    1. Fröhlich H, Balling R, Beerenwinkel N, Kohlbacher O, Kumar S, Lengauer T, et al. From hype to reality: data science enabling personalized medicine. BMC Med. 2018;16(1):150. doi: 10.1186/s12916-018-1122-7.
    1. WHO. Health equity [Internet]. World Health Organization; 2019. [cited 2019 November 18]. Available from: .
    1. Aronson SJ, Rehm HL. Building the foundation for genomics in precision medicine. Nature. 2015;526(7573):336–342. doi: 10.1038/nature15816.
    1. Rubin R. A precision Medicine approach to clinical trials. JAMA. 2016;316(19):1953–1955. doi: 10.1001/jama.2016.12137.
    1. Ginsburg GS, Phillips KA. Precision Medicine: from science to value. Health affairs (Project Hope) 2018;37(5):694–701. doi: 10.1377/hlthaff.2017.1624.
    1. Bhopal RS. Racism in health and health care in Europe: reality or mirage? Eur J Pub Health. 2007;17(3):238–241. doi: 10.1093/eurpub/ckm039.
    1. Cohn EG, Henderson GE, Appelbaum PS. Distributive justice, diversity, and inclusion in precision medicine: what will success look like? Genet Med. 2016;19:157. doi: 10.1038/gim.2016.92.
    1. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87(11):1773–1778. doi: 10.2105/AJPH.87.11.1773.
    1. Lee SSJ, Cho MK, Kraft SA, Varsava N, Gillespie K, Ormond KE, et al. “I don’t want to be Henrietta lacks”: diverse patient perspectives on donating biospecimens for precision medicine research. Genet Med. 2019;21(1):107–113. doi: 10.1038/s41436-018-0032-6.
    1. Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3(2):e19-e. doi: 10.1371/journal.pmed.0030019.
    1. Mersha TB, Abebe T. Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities. Hum Genomics. 2015;9(1):1. doi: 10.1186/s40246-014-0023-x.
    1. Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nat News. 2016;538(7624):161. doi: 10.1038/538161a.
    1. Roeder A. America is failing its black mothers [Internet]. Harvard Public Health; 2019. [cited 2019 April 8]. Available from: .
    1. CDC. Pregnancy Mortality Surveillance System [Internet]. Centers for Disease Control and Prevention; 2020. [cited 2020 February 11]. Available from: .
    1. Amnesty International . Deadly delivery the maternal health care crisis in the USA. Amnesty International: United Kingdom; 2010.
    1. Paradies Y. A systematic review of empirical research on self-reported racism and health. Int J Epidemiol. 2006;35(4):888–901. doi: 10.1093/ije/dyl056.
    1. Tjaden LA, Noordzij M, van Stralen KJ, Kuehni CE, Raes A, Cornelissen EA, et al. Racial disparities in access to and outcomes of kidney transplantation in children, adolescents, and young adults: results from the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European renal association-European Dialysis and transplant association) registry. Am J Kidney Dis. 2016;67(2):293–301. doi: 10.1053/j.ajkd.2015.09.023.
    1. Stronks K, Snijder MB, Peters RJG, Prins M, Schene AH, Zwinderman AH. Unravelling the impact of ethnicity on health in Europe: the HELIUS study. BMC Public Health. 2013;13:402. doi: 10.1186/1471-2458-13-402.
    1. Mensah GA, Jaquish C, Srinivas P, Papanicolaou GJ, Wei GS, Redmond N, et al. Emerging concepts in precision Medicine and cardiovascular diseases in racial and ethnic minority populations. Circ Res. 2019;125(1):7–13. doi: 10.1161/CIRCRESAHA.119.314970.
    1. Bayer R, Galea S. Public health in the precision-Medicine era. N Engl J Med. 2015;373(6):499–501. doi: 10.1056/NEJMp1506241.
    1. Kraft SA, Cho MK, Gillespie K, Halley M, Varsava N, Ormond KE, et al. Beyond consent: building trusting relationships with diverse populations in precision Medicine research. Am J Bioeth. 2018;18(4):3–20. doi: 10.1080/15265161.2018.1431322.
    1. Williams DR, Mohammed SA. Discrimination and racial disparities in health: evidence and needed research. J Behav Med. 2009;32(1):20–47. doi: 10.1007/s10865-008-9185-0.
    1. Oxford English Dictionary. Racism [Internet]. Oxford University Press; 2019. [cited 2019 April 8]. Available from: .
    1. Viruell-Fuentes EA, Miranda PY, Abdulrahim S. More than culture: structural racism, intersectionality theory, and immigrant health. Soc Sci Med. 2012;75(12):2099–2106. doi: 10.1016/j.socscimed.2011.12.037.
    1. Bailey Z, Krieger N, Agénor M, Graves J, Linos N, Bassett M. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. doi: 10.1016/S0140-6736(17)30569-X.
    1. Bassett MT, Graves JD. Uprooting institutionalized racism as public health practice. Am J Public Health. 2018;108(4):457–458. doi: 10.2105/AJPH.2018.304314.
    1. Ramaswami R, Bayer R, Galea S. Precision Medicine from a public health perspective. Annu Rev Public Health. 2018;39:153–168. doi: 10.1146/annurev-publhealth-040617-014158.
    1. Eastman P. IOM report: minorities receive unequal medical treatment even when access is similar. Oncol Times. 2002;24(5):31–32. doi: 10.1097/01.COT.0000285929.98853.6b.
    1. Ferryman K, Pitcan M. Fairness in Precision Medicine. Data & Society. 2018.
    1. Hicken MT, Kravitz-Wirtz N, Durkee M, Jackson JS. Racial inequalities in health: Framing future research. Soc Sci Med. 2018;199:11–18. doi: 10.1016/j.socscimed.2017.12.027.
    1. Lamont M, Beljean S, Clair M. What is missing? Cultural processes and causal pathways to inequality. Soc Econ Rev. 2014;12(3):573–608. doi: 10.1093/ser/mwu011.
    1. United Nations. Leaving no one behind [Internet]. United Nations; 2016. [cited 2019 April 8]. Available from: .
    1. Chambers DA, Feero WG, Khoury MJ. Convergence of implementation science, precision Medicine, and the learning health care system: a new model for biomedical research. JAMA. 2016;315(18):1941–1942. doi: 10.1001/jama.2016.3867.
    1. Fisher ES, Shortell SM, Savitz LA. Implementation science: a potential catalyst for delivery system reform. JAMA. 2016;315(4):339–340. doi: 10.1001/jama.2015.17949.
    1. Blumenthal GM, Mansfield E, Pazdur R. Next-generation sequencing in oncology in the era of precision Medicine. JAMA Oncol. 2016;2(1):13–14. doi: 10.1001/jamaoncol.2015.4503.
    1. Morris LGT, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, et al. The molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platform. JAMA Oncol. 2017;3(2):244–255. doi: 10.1001/jamaoncol.2016.1790.
    1. Hann KEJ, Freeman M, Fraser L, Waller J, Sanderson SC, Rahman B, et al. Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health. 2017;17(1):503. doi: 10.1186/s12889-017-4375-8.
    1. Hall WJ, Chapman MV, Lee KM, Merino YM, Thomas TW, Payne BK, et al. Implicit racial/ethnic Bias among health care professionals and its influence on health care outcomes: a systematic review. Am J Public Health. 2015;105(12):e60–e76. doi: 10.2105/AJPH.2015.302903.
    1. van Ryn M, Burgess DJ, Dovidio JF, Phelan SM, Saha S, Malat J, et al. The impact of racism on clinician cognition, behavior, and clinical decision making. Du Bois Rev. 2011;8(1):199–218. doi: 10.1017/S1742058X11000191.
    1. Hoffman KM, Trawalter S, Axt JR, Oliver MN. Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proc Natl Acad Sci. 2016;113(16):4296–4301. doi: 10.1073/pnas.1516047113.
    1. Gerber JS, Prasad PA, Localio AR, Fiks AG, Grundmeier RW, Bell LM, et al. Racial differences in antibiotic prescribing by primary care pediatricians. Pediatrics. 2013;131(4):677–684. doi: 10.1542/peds.2012-2500.
    1. Puumala SE, Burgess KM, Kharbanda AB, Zook HG, Castille DM, Pickner WJ, et al. The role of Bias by emergency department providers in Care for American Indian Children. Med Care. 2016;54(6):562–569. doi: 10.1097/MLR.0000000000000533.
    1. Penner LA, Blair IV, Albrecht TL, Dovidio JF. Reducing racial health care disparities: a social psychological analysis. Policy Insights Behav Brain Sci. 2014;1(1):204–212. doi: 10.1177/2372732214548430.
    1. Penner LA, Dovidio JF, West TV, Gaertner SL, Albrecht TL, Dailey RK, et al. Aversive racism and medical interactions with black patients: a field study. J Exp Soc Psychol. 2010;46(2):436–440. doi: 10.1016/j.jesp.2009.11.004.
    1. Williams DR, Wyatt R. Racial Bias in health care and health: challenges and opportunities. JAMA. 2015;314(6):555–556. doi: 10.1001/jama.2015.9260.
    1. D'Agostino RB, Sr, Grundy S, Sullivan LM, Wilson P. For the CHDRPG. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180–187. doi: 10.1001/jama.286.2.180.
    1. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003;24(10):937–945. doi: 10.1016/S0195-668X(03)00081-2.
    1. Liu J, Hong Y, D'Agostino RB, Sr, Wu Z, Wang W, Sun J, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study. JAMA. 2004;291(21):2591–2599. doi: 10.1001/jama.291.21.2591.
    1. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56. doi: 10.1038/s41591-018-0300-7.
    1. Gebru T, Morgenstern J, Vecchione B, Vaughan JW, Wallach H, Daumeé H, III, et al. Datasheets for datasets. arXiv preprint arXiv:180309010. 2018.
    1. Žliobaitė I. Measuring discrimination in algorithmic decision making. Data Min Knowl Disc. 2017;31(4):1060–1089. doi: 10.1007/s10618-017-0506-1.
    1. Courtland R. Bias detectives: the researchers striving to make algorithms fair. Nature. 2018;558(7710):357–360. doi: 10.1038/d41586-018-05469-3.
    1. CB Insights. The Future Of Clinical Trials: How AI & Big Tech Could Make Drug Development Cheaper, Faster, & More Effective [Internet]. CB Insights; 2018. [cited 2019 May 6]. Available from: .
    1. DEEP 6 AI. How it works [Internet]. DEEP 6 AI; 2019. [cited 2019 May 6]. Available from: .
    1. Microsoft. Microsoft Healthcare Bot [Internet]. Microsoft; 2019. [cited 2019 June 5]. Available from: .
    1. Bass D. Microsoft Built a Bot to Match Patients to Clinical Trials [Internet]. Bloomberg; 2019. [cited 2019 June 5]. Available from: .
    1. Obermeyer Z, Mullainathan S. Dissecting Racial Bias in an Algorithm that Guides Health Decisions for 70 Million People. Proceedings of the Conference on Fairness, Accountability, and Transparency; 2019; Atlanta, GA, USA. New York: ACM; 2019.
    1. Nordling L. A fairer way forward for AI in health care. Nature. 2019;573(7775):S103–S1s5. doi: 10.1038/d41586-019-02872-2.
    1. Williams DR, Collins C. Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep. 2001;116(5):404–416. doi: 10.1016/S0033-3549(04)50068-7.
    1. Bulatao RA, Anderson NB. Understanding racial and ethnic differences in health in late life: a research agenda: National Academies Press. 2004.
    1. Rhee TG, Marottoli RA, Van Ness PH, Levy BR. Impact of perceived racism on healthcare access among older minority adults. Am J Prev Med. 2019;56(4):580–585. doi: 10.1016/j.amepre.2018.10.010.
    1. Gaskin DJ, Dinwiddie GY, Chan KS, McCleary R. Residential segregation and disparities in health care services utilization. Med Care Res Rev. 2012;69(2):158–175. doi: 10.1177/1077558711420263.
    1. PMC. Personalized Medicine at FDA: A Progress & Outlook Report [Internet]. Personalized Medicine Coalition; 2019. [cited 2019 November 15]. Available from: .
    1. Farooq F, Strouse J. Disparities in foundation and Federal Support and development of new therapeutics for sickle cell disease and cystic fibrosis [abstract] Blood. 2018;132(Suppl 1):4687. doi: 10.1182/blood-2018-99-115609.
    1. O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891–1904. doi: 10.1016/S0140-6736(09)60327-5.
    1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031. doi: 10.1016/S0140-6736(10)61029-X.
    1. PMC. Personalized Medicine at FDA: 2014 Progress Report [Internet]. Personalized Medicine Coalition. [cited 2019 November 15]. Available from: .
    1. PMC. Personalized Medicine at FDA: 2015 Progress Report [Internet]. Personalized Medicine Coalition. [cited 2019 November 15] . Available from: .
    1. PMC. Personalized Medicine at FDA: 2016 Progress Report [Internet]. Personalized Medicine Coalition. [cited 2019 November 15]. Available from: .
    1. PMC. Personalized Medicine at FDA: 2017 Progress Report [Internet]. Personalized Medicine Coalition. [cited 2019 November 15]. Available from:
    1. Balasegaram M. MSF response to Bayer CEO statement that medicines developed only for western patients [Internet]. Médecins Sans Frontières; 2014. [cited 2019 November 15]. Available from:
    1. Adjekum A, Ienca M, Vayena E. What is trust? Ethics and risk governance in precision Medicine and predictive analytics. Omics. 2017;21(12):704–710. doi: 10.1089/omi.2017.0156.
    1. The All of Us Research Program Investigators The “all of us” research program. N Engl J Med. 2019;381(7):668–676. doi: 10.1056/NEJMsr1809937.
    1. UK Biobank data on 500,000 people paves way to precision medicine. Nature. 2018;562(7726):163–4.
    1. Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. doi: 10.1371/journal.pmed.1001779.
    1. Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of Sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026–1034. doi: 10.1093/aje/kwx246.
    1. UK Biobank. Access matter: representativeness of the UK Biobank resource [Internet]. UK Biobank; 2017. [cited 2019 November 15]. Available from:
    1. Keyes KM, Westreich D. UK Biobank, big data, and the consequences of non-representativeness. Lancet. 2019;393(10178):1297. doi: 10.1016/S0140-6736(18)33067-8.
    1. DATA USA. Physicians & surgeons [Internet]. DATA USA. [cited 2020 February 11]. Available from: .
    1. Cohan D. Racist like me - a call to self-reflection and action for white physicians. N Engl J Med. 2019;380(9):805–807. doi: 10.1056/NEJMp1814269.
    1. The European Parliament. European Parliament resolution of 26 March 2019 on fundamental rights of people of African descent in Europe (2018/2899(RSP)) [Internet]. The European Parliament; 2019. [cited 2019 November 15]. Available from: .
    1. Project Implicit. About us [Internet]. Project Implicit; 2011. [cited 2019 June 3]. Available from:
    1. Orchard J, Price J. County-level racial prejudice and the black-white gap in infant health outcomes. Soc Sci Med. 2017;181:191–198. doi: 10.1016/j.socscimed.2017.03.036.
    1. Sabin JA, Riskind RG, Nosek BA. Health care Providers' Implicit and explicit attitudes toward lesbian women and gay men. Am J Public Health. 2015;105(9):1831–1841. doi: 10.2105/AJPH.2015.302631.
    1. Graham L, Brown-Jeffy S, Aronson R, Stephens C. Critical race theory as theoretical framework and analysis tool for population health research. Crit Public Health. 2011;21(1):81–93. doi: 10.1080/09581596.2010.493173.
    1. Kaminski ME, Selbst AD. The Legislation That Targets the Racist Impacts of Tech [Internet]. The New York Times; 2019. [cited 2019 June 3]. Available from:
    1. Schneble CO, Elger BS, Shaw D. The Cambridge Analytica affair and internet-mediated research. EMBO Rep. 2018;19(8):e46579.
    1. Corbin K. HUD Is Suing Facebook For Housing Discrimination[Internet]. Forbes; 2019. [cited 2019 June 3]. Available from:
    1. Reisman D, Schultz J, Crawford K, Whittaker M. Algorithmic impact assessments: a practical framework for public agency accountability [Internet]. AI NOW Institute; 2018. [cited 2019 June 5]. Available from: .
    1. Bellamy R, Dey K, Hind M, Hoffman S, Houde S, Kannan K, et al. AI Fairness 360: An extensible toolkit for detecting and mitigating algorithmic bias. IBM J Res Dev. 2019;63(4/5):4:1–4:15. doi: 10.1147/JRD.2019.2942287.
    1. Shaw D, Elger BS, Colledge F. What is a biobank? Differing definitions among biobank stakeholders. Clin Genet. 2014;85(3):223–227. doi: 10.1111/cge.12268.
    1. Tutton R. Biobanks and the inclusion of racial/ethnic minorities. Race/Ethnicity: Multidisciplinary Global Contexts. 2009. pp. 75–95.
    1. Stanford Medicine. BRAICELET: Bio-Repository for American Indian Capacity, Education, Law, Economics and Technology [Internet]. Stanford Medicine; 2019. [cited 2019 April 11]. Available from:
    1. Mulder Nicola, Abimiku Alash'le, Adebamowo Sally N, de Vries Jantina, Matimba Alice, Olowoyo Paul, Ramsay Michele, Skelton Michelle, Stein Dan J. H3Africa: current perspectives. Pharmacogenomics and Personalized Medicine. 2018;Volume 11:59–66. doi: 10.2147/PGPM.S141546.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner